Christoph Seidel (@chrisalesei) 's Twitter Profile
Christoph Seidel

@chrisalesei

Consultant Hematology / Oncology Hamburg - Eppendorf, Germany

ID: 884110793184350209

calendar_today09-07-2017 18:03:33

82 Tweet

48 Takipçi

104 Takip Edilen

Christoph Seidel (@chrisalesei) 's Twitter Profile Photo
Christoph Seidel
@chrisalesei

2 years ago

This trial demonstrates non-inferiority of tislelizumab agains sorafenib in unresectabe 1st l. HCC ➡️ why against SO, which is no standard of care? ➡️ why a non-inferiority trial against SO, which performed bad in the real life setting acoording SEER? jamanetwork.com/journals/jamao…